Normal view MARC view ISBD view

Clinical outcome of early-stage endometroid adenocarcinoma: a tertiary cancer center experience

In International Journal of Gynecological Cancer
Contributor(s): Shrivasatava S | Gupta S | Ghosh J | T S S | Kerkar R | Maheshwari A | Chopra S | Engineer R | Mulla S | Saoba S | Ganesh B | Aggarwal A | drumeshm@gmail.com | Mahantshetty U.
Material type: materialTypeLabelArticleSeries: Vol 23 Issues 8.Publisher: 2013Description: 1446-1452.Subject(s): Adjuvant radiation | Prognostic factors | Survivals | Endometroid adenocarcinoma (type I histology) | Endometrial cancers | DDC classification: In: International Journal of Gynecological CancerSummary: Objective: Endometrial cancer (EC) outcome data from developing countries are sparse. We undertook this retrospective analysis to report outcome in our patient population. Materials and Methods: Two hundred forty-nine patients with stage I and II and type I histology ECs referred/treated at our institution from 1998 to 2004 were analyzed. All the details including demographic profile, surgical and histopathological details, as well as International Federation of Gynecology and Obstetrics stage and adjuvant therapy were compiled. The 1988 International Federation of Gynecology and Obstetrics staging and risk stratification were performed on the basis of PORTEC risk groups. Results: With a median age of 54 years (2672 years), 136 patients (55%) underwent surgery elsewhere; 118 (47.3%) underwent a complete surgical staging. There were 60 (24.1%), 124 (49.8%), 65 (26.1%) patients in the low-risk (LR), intermediate-risk (IR), and high-risk (HR) groups, respectively. Adjuvant radiation was given in 160 pat
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Articles Articles Tata Memorial Hospital
Available AR15805

Objective: Endometrial cancer (EC) outcome data from developing countries are sparse. We undertook this retrospective analysis to report outcome in our patient population.

Materials and Methods: Two hundred forty-nine patients with stage I and II and type I histology ECs referred/treated at our institution from 1998 to 2004 were analyzed. All the details including demographic profile, surgical and histopathological details, as well as International Federation of Gynecology and Obstetrics stage and adjuvant therapy were compiled. The 1988 International Federation of Gynecology and Obstetrics staging and risk stratification were performed on the basis of PORTEC risk groups.

Results: With a median age of 54 years (2672 years), 136 patients (55%) underwent surgery elsewhere; 118 (47.3%) underwent a complete surgical staging. There were 60 (24.1%), 124 (49.8%), 65 (26.1%) patients in the low-risk (LR), intermediate-risk (IR), and high-risk (HR) groups, respectively. Adjuvant radiation was given in 160 pat

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha